Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human, Mouse

Applications

Validated:

Immunohistochemistry, Western Blot, Flow Cytometry, CyTOF-ready

Cited:

Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot, Neutralization, Flow Cytometry, Immunocytochemistry, Binding Assay, Dot Blot, ELISA Development

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG
Loading...

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant human EPCR
Ser18-Ser210
Accession # Q9UNN8

Specificity

Detects human EPCR in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 20% cross-reactivity with recombinant mouse EPCR is observed.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Scientific Data Images for Human EPCR Antibody

Detection of Human EPCR antibody by Western Blot.

Detection of Human EPCR by Western Blot.

Western blot shows lysates of human skin tissue, human placenta tissue, and HUVEC human umbilical vein endothelial cells. PVDF membrane was probed with 0.25 µg/mL of Goat Anti-Human EPCR Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2245) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF017). A specific band was detected for EPCR at approximately 40-45 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

EPCR antibody in Human Liver by Immunohistochemistry (IHC-P).

EPCR in Human Liver.

EPCR was detected in immersion fixed paraffin-embedded sections of human liver using 1.7 µg/mL Goat Anti-Human EPCR Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2245) overnight at 4 °C. Tissue was stained with the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.

Detection of EPCR by Immunocytochemistry/ Immunofluorescence

Detection of EPCR by Immunocytochemistry/ Immunofluorescence

Effect of hypoxia on endothelial hemoglobin & EPCR expression.(A) Representative WB of human cardiac microvascular endothelial cultured under hypoxia (1% oxygen) showing HIF1A, NRF2, EPCR, HBA, & ACTB as a protein loading control; n = 3 biological replicates. Values under each blot image indicate fold changes versus results in control (as determined by normalization to the loading control run on same blot). (B & C) Representative immunofluorescent images & quantification of human microvascular endothelial cultured under hypoxia at different time points, as indicated, & stained for HBA (red) & NRF2 (green). Small image in 24-hour NRF2 panel shows overlay image of the cell. *P < 0.05 & ****P < 0.0001 versus control calculated using 1-way ANOVA, Bonferroni’s multiple-comparison test. (D) Representative immunofluorescent high-resolution images showing human microvascular endothelial cultured under hypoxia (1% oxygen) & stained for PAR1 (green) & EPCR (purple) at the left panel or for PAR1 (green), EPCR (purple), & lysosomal tracker (Lyso; red) at the right panel; n = 3 biological replicates. Scale bars: 10 μm. (E & F) WB & quantification analysis of human microvascular endothelial cultured under hypoxia (1% oxygen) showing NRF2, caveolin-1, & beta -actin (ACTB) as a loading control; n = 3 biological replicates. ***P < 0.001 & ****P < 0.0001; 1-way ANOVA, Bonferroni’s multiple-comparison test. (G & H) Representative immunofluorescent images & quantification analysis showing human microvascular endothelial cultured under hypoxia (1% oxygen), treated with EPCR-blocking antibody (20 μg/mL), as indicated, & stained for HBA (red) & EPCR (purple). Scale bars: 10 μm. **P < 0.01, ***P < 0.001, & ****P < 0.0001 versus control ; 1-way ANOVA, Bonferroni’s multiple-comparison test. Image collected & cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35700057), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of EPCR by Western Blot

Detection of EPCR by Western Blot

Effect of hypoxia on endothelial hemoglobin & EPCR expression.(A) Representative WB of human cardiac microvascular endothelial cultured under hypoxia (1% oxygen) showing HIF1A, NRF2, EPCR, HBA, & ACTB as a protein loading control; n = 3 biological replicates. Values under each blot image indicate fold changes versus results in control (as determined by normalization to the loading control run on same blot). (B & C) Representative immunofluorescent images & quantification of human microvascular endothelial cultured under hypoxia at different time points, as indicated, & stained for HBA (red) & NRF2 (green). Small image in 24-hour NRF2 panel shows overlay image of the cell. *P < 0.05 & ****P < 0.0001 versus control calculated using 1-way ANOVA, Bonferroni’s multiple-comparison test. (D) Representative immunofluorescent high-resolution images showing human microvascular endothelial cultured under hypoxia (1% oxygen) & stained for PAR1 (green) & EPCR (purple) at the left panel or for PAR1 (green), EPCR (purple), & lysosomal tracker (Lyso; red) at the right panel; n = 3 biological replicates. Scale bars: 10 μm. (E & F) WB & quantification analysis of human microvascular endothelial cultured under hypoxia (1% oxygen) showing NRF2, caveolin-1, & beta -actin (ACTB) as a loading control; n = 3 biological replicates. ***P < 0.001 & ****P < 0.0001; 1-way ANOVA, Bonferroni’s multiple-comparison test. (G & H) Representative immunofluorescent images & quantification analysis showing human microvascular endothelial cultured under hypoxia (1% oxygen), treated with EPCR-blocking antibody (20 μg/mL), as indicated, & stained for HBA (red) & EPCR (purple). Scale bars: 10 μm. **P < 0.01, ***P < 0.001, & ****P < 0.0001 versus control ; 1-way ANOVA, Bonferroni’s multiple-comparison test. Image collected & cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35700057), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of EPCR by Western Blot

Detection of EPCR by Western Blot

Effect of hypoxia on endothelial hemoglobin & EPCR expression.(A) Representative WB of human cardiac microvascular endothelial cultured under hypoxia (1% oxygen) showing HIF1A, NRF2, EPCR, HBA, & ACTB as a protein loading control; n = 3 biological replicates. Values under each blot image indicate fold changes versus results in control (as determined by normalization to the loading control run on same blot). (B & C) Representative immunofluorescent images & quantification of human microvascular endothelial cultured under hypoxia at different time points, as indicated, & stained for HBA (red) & NRF2 (green). Small image in 24-hour NRF2 panel shows overlay image of the cell. *P < 0.05 & ****P < 0.0001 versus control calculated using 1-way ANOVA, Bonferroni’s multiple-comparison test. (D) Representative immunofluorescent high-resolution images showing human microvascular endothelial cultured under hypoxia (1% oxygen) & stained for PAR1 (green) & EPCR (purple) at the left panel or for PAR1 (green), EPCR (purple), & lysosomal tracker (Lyso; red) at the right panel; n = 3 biological replicates. Scale bars: 10 μm. (E & F) WB & quantification analysis of human microvascular endothelial cultured under hypoxia (1% oxygen) showing NRF2, caveolin-1, & beta -actin (ACTB) as a loading control; n = 3 biological replicates. ***P < 0.001 & ****P < 0.0001; 1-way ANOVA, Bonferroni’s multiple-comparison test. (G & H) Representative immunofluorescent images & quantification analysis showing human microvascular endothelial cultured under hypoxia (1% oxygen), treated with EPCR-blocking antibody (20 μg/mL), as indicated, & stained for HBA (red) & EPCR (purple). Scale bars: 10 μm. **P < 0.01, ***P < 0.001, & ****P < 0.0001 versus control ; 1-way ANOVA, Bonferroni’s multiple-comparison test. Image collected & cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35700057), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of EPCR by Immunocytochemistry/ Immunofluorescence

Detection of EPCR by Immunocytochemistry/ Immunofluorescence

Effect of hypoxia on endothelial hemoglobin & EPCR expression.(A) Representative WB of human cardiac microvascular endothelial cultured under hypoxia (1% oxygen) showing HIF1A, NRF2, EPCR, HBA, & ACTB as a protein loading control; n = 3 biological replicates. Values under each blot image indicate fold changes versus results in control (as determined by normalization to the loading control run on same blot). (B & C) Representative immunofluorescent images & quantification of human microvascular endothelial cultured under hypoxia at different time points, as indicated, & stained for HBA (red) & NRF2 (green). Small image in 24-hour NRF2 panel shows overlay image of the cell. *P < 0.05 & ****P < 0.0001 versus control calculated using 1-way ANOVA, Bonferroni’s multiple-comparison test. (D) Representative immunofluorescent high-resolution images showing human microvascular endothelial cultured under hypoxia (1% oxygen) & stained for PAR1 (green) & EPCR (purple) at the left panel or for PAR1 (green), EPCR (purple), & lysosomal tracker (Lyso; red) at the right panel; n = 3 biological replicates. Scale bars: 10 μm. (E & F) WB & quantification analysis of human microvascular endothelial cultured under hypoxia (1% oxygen) showing NRF2, caveolin-1, & beta -actin (ACTB) as a loading control; n = 3 biological replicates. ***P < 0.001 & ****P < 0.0001; 1-way ANOVA, Bonferroni’s multiple-comparison test. (G & H) Representative immunofluorescent images & quantification analysis showing human microvascular endothelial cultured under hypoxia (1% oxygen), treated with EPCR-blocking antibody (20 μg/mL), as indicated, & stained for HBA (red) & EPCR (purple). Scale bars: 10 μm. **P < 0.01, ***P < 0.001, & ****P < 0.0001 versus control ; 1-way ANOVA, Bonferroni’s multiple-comparison test. Image collected & cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35700057), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human EPCR Antibody

Application
Recommended Usage

CyTOF-ready

Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.

Flow Cytometry

0.25 µg/106 cells
Sample: HUVEC human umbilical vein endothelial cells

Immunohistochemistry

1-15 µg/mL
Sample: Immersion fixed paraffin-embedded sections of human liver

Western Blot

0.25 µg/mL
Sample: Human skin tissue, human placenta tissue, and HUVEC human umbilical vein endothelial cells

Flow Cytometry Panel Builder

Bio-Techne Knows Flow Cytometry

Save time and reduce costly mistakes by quickly finding compatible reagents using the Panel Builder Tool.

Advanced Features

  • Spectra Viewer - Custom analysis of spectra from multiple fluorochromes
  • Spillover Popups - Visualize the spectra of individual fluorochromes
  • Antigen Density Selector - Match fluorochrome brightness with antigen density
Build Your Panel Now

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.


Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: EPCR

EPCR is a type I transmembrane glycoprotein in the CD1/MHC family. It is expressed most strongly in the endothelial cells of arteries and veins in heart and lung. Membrane bound EPCR is released by metalloproteolytic cleavage to generate the soluble receptor. Protein C is a vitamin K-dependent serine protease that plays a major role in blood coagulation. Binding of Protein C to EPCR leads to the proteolytic activation of PAR1 (protease-activated receptor 1) on endothelial cells and subsequent up-regulation of Protein C-induced genes.  The extracellular domain of human and mouse EPCR shares approximately 61% amino acid sequence homology.

Long Name

Endothelial Protein C Receptor

Alternate Names

CCD41, CD201, PROCR

Entrez Gene IDs

10544 (Human); 19124 (Mouse)

Gene Symbol

PROCR

UniProt

Additional EPCR Products

Product Documents for Human EPCR Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human EPCR Antibody

For research use only

Citations for Human EPCR Antibody

Customer Reviews for Human EPCR Antibody

There are currently no reviews for this product. Be the first to review Human EPCR Antibody and earn rewards!

Have you used Human EPCR Antibody?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies